Related references
Note: Only part of the references are listed.Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease
Paula Chlebanowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids
Hongwon Kim et al.
STEM CELL REPORTS (2019)
Neurotoxicity of the pesticide rotenone on neuronal polarization: a mechanistic approach
Mariano Bisbal et al.
NEURAL REGENERATION RESEARCH (2019)
Neurotoxin-Induced Animal Models of Parkinson Disease: Pathogenic Mechanism and Assessment
Xian-Si Zeng et al.
ASN NEURO (2018)
Genetic risk factors in Parkinson's disease
K. J. Billingsley et al.
CELL AND TISSUE RESEARCH (2018)
Generation of human brain region-specific organoids using a miniaturized spinning bioreactor
Xuyu Qian et al.
NATURE PROTOCOLS (2018)
LRRK2 kinase in Parkinson's disease
Dario R. Alessi et al.
SCIENCE (2018)
C-terminal calcium binding of alpha-synuclein modulates synaptic vesicle interaction
Janin Lautenschlager et al.
NATURE COMMUNICATIONS (2018)
Modeling Parkinson's Disease in C. elegans
Jason F. Cooper et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Zebrafish as an Animal Model for Drug Discovery in Parkinson's Disease and Other Movement Disorders: A Systematic Review
Rita L. Vaz et al.
FRONTIERS IN NEUROLOGY (2018)
Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease
Andrew B. West
EXPERIMENTAL NEUROLOGY (2017)
Methyl-4-phenylpyridinium (MPP plus ) differentially affects monoamine release and re-uptake in murine embryonic stem cell-derived dopaminergic and serotonergic neurons
Yasmina Marti et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2017)
T cells from patients with Parkinson's disease recognize α-synuclein peptides
David Sulzer et al.
NATURE (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
C-elegans as a model system to accelerate discovery for Parkinson disease
Bryan A. Martinez et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2017)
The Rodent Forced Swim Test Measures Stress-Coping Strategy, Not Depression-like Behavior
Kathryn G. Commons et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Neuroprotective Effects of Tanshinone I Against 6-OHDA-Induced Oxidative Stress in Cellular and Mouse Model of Parkinson's Disease Through Upregulating Nrf2
Xu Jing et al.
NEUROCHEMICAL RESEARCH (2016)
Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons
Junghyun Jo et al.
CELL STEM CELL (2016)
Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease
Douglas A. Grow et al.
STEM CELL RESEARCH (2016)
Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson's disease
Pingping Song et al.
PROTEIN & CELL (2016)
The Polg Mutator Phenotype Does Not Cause Dopaminergic Neurodegeneration in DJ-1-Deficient Mice
David N. Hauser et al.
ENEURO (2015)
Why Primate Models Matter
Kimberley A. Phillips et al.
AMERICAN JOURNAL OF PRIMATOLOGY (2014)
Pharmacological Strategies for the Management of Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease
Eva Schaeffer et al.
CNS DRUGS (2014)
Dopamine Dynamics and Signaling in Drosophila: An Overview of Genes, Drugs and Behavioral Paradigms
Shinya Yamamoto et al.
EXPERIMENTAL ANIMALS (2014)
Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through Protein Kinase A
Ruben K. Dagda et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Mike A. Nalls et al.
NATURE GENETICS (2014)
A mutation in Drosophila methuselah resists paraquat induced Parkinson-like phenotypes
Arvind K. Shukla et al.
NEUROBIOLOGY OF AGING (2014)
Targeting the Intrinsically Disordered Structural Ensemble of α-Synuclein by Small Molecules as a Potential Therapeutic Strategy for Parkinson's Disease
Gergely Toth et al.
PLOS ONE (2014)
Unaltered Striatal Dopamine Release Levels in Young Parkin Knockout, Pink1 Knockout, DJ-1 Knockout and LRRK2 R1441G Transgenic Mice
Gonzalo Sanchez et al.
PLOS ONE (2014)
TRAP1 rescues PINK1 loss-of-function phenotypes
Li Zhang et al.
HUMAN MOLECULAR GENETICS (2013)
Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats
Nagaraja Haleagrahara et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2013)
Neuroprotective Function of DJ-1 in Parkinson's Disease
Hiroyoshi Ariga et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Function and Characteristics of PINK1 in Mitochondria
Satoru Matsuda et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Using Human Pluripotent Stem Cell-Derived Dopaminergic Neurons to Evaluate Candidate Parkinson's Disease Therapeutic Agents in MPP+ and Rotenone Models
Jun Peng et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Overexpression of Parkin Ameliorates Dopaminergic Neurodegeneration Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice
Minjuan Bian et al.
PLOS ONE (2012)
The Tail Suspension Test
Adem Can et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
Parkinsonian Rotenone Mouse Model: Reevaluation of Long-Term Administration of Rotenone in C57BL/6 Mice
Masatoshi Inden et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2011)
LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
Ha Nam Nguyen et al.
CELL STEM CELL (2011)
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Karin Wirdefeldt et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2011)
Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background
Kavita Prasad et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2011)
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
Michael J. Devine et al.
NATURE COMMUNICATIONS (2011)
A Guide to Neurotoxic Animal Models of Parkinson's Disease
Kim Tieu
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Behavioral phenotyping of mouse models of Parkinson's disease
Tonya N. Taylor et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: Modulation by the Nrf2/Trx axis
Mireia Niso-Santano et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Melatonin Treatment Potentiates Neurodegeneration in a Rat Rotenone Parkinson's Disease Model
Victor Tapias et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Missing pieces in the Parkinson's disease puzzle
Jose A. Obeso et al.
NATURE MEDICINE (2010)
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Byoung Dae Lee et al.
NATURE MEDICINE (2010)
Genetic Animal Models of Parkinson's Disease
Ted M. Dawson et al.
NEURON (2010)
DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway
Hossein Aleyasin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Two new test methods to quantify motor deficits in a marmoset model for Parkinson's disease
Peternella S. Verhave et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Pathogenic Mutations Shift the Equilibria of α-Synuclein Single Molecules towards Structured Conformers
Marco Brucale et al.
CHEMBIOCHEM (2009)
Sleep disorders in Parkinson's disease: The contribution of the MPTP non-human primate model
Quentin Barraud et al.
EXPERIMENTAL NEUROLOGY (2009)
Molecular pathogenesis of Parkinson disease: insights from genetic studies
Thomas Gasser
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Absence of nigral degeneration in aged parkin/DJ-1/PINK1 triple knockout mice
Tohru Kitada et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
No Lewy Pathology in Monkeys with Over 10 Years of Severe MPTP Parkinsonism
Glenda Halliday et al.
MOVEMENT DISORDERS (2009)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
Parkinson Phenotype in Aged PINK1-Deficient Mice Is Accompanied by Progressive Mitochondrial Dysfunction in Absence of Neurodegeneration
Suzana Gispert et al.
PLOS ONE (2009)
Parkinson's disease: genetic versus toxin-induced rodent models
Muegen Terzioglu et al.
FEBS JOURNAL (2008)
Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson's disease accelerate age-related neurodegeneration
Jun Peng et al.
JOURNAL OF NEUROSCIENCE (2007)
Nonhuman primate models of Parkinson's disease
Marina E. Emborg
ILAR JOURNAL (2007)
End-of-dose wearing off in Parkinson disease: A 9-question survey assessment
Mark Stacy et al.
CLINICAL NEUROPHARMACOLOGY (2006)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Jeehye Park et al.
NATURE (2006)
Behavioral models of Parkinson's disease in rodents: A new look at an old problem
Gloria E. Meredith et al.
MOVEMENT DISORDERS (2006)
A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?
K Ossowska et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice
LN Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Identification of motor and nonmotor wearing-off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment
M Stacy et al.
MOVEMENT DISORDERS (2005)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
EM Valente et al.
SCIENCE (2004)
Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP
A Schober
CELL AND TISSUE RESEARCH (2004)
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
V Bonifati et al.
SCIENCE (2003)
The herbicide paraquat causes up-regulation and aggregation of α-synuclein in mice -: Paraquat and α-synuclein
AB Manning-Bog et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Behavioral phenotyping of the MPTP mouse model of Parkinson's disease
M Sedelis et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Lack of nigral pathology in transgenic mice expressing human α-synuclein driven by the tyrosine hydroxylase promoter
Y Matsuoka et al.
NEUROBIOLOGY OF DISEASE (2001)
Mouse model of Parkinsonism: A comparison between subacute MPTP and chronic MPTP/probenecid treatment
E Petroske et al.
NEUROSCIENCE (2001)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)
Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey
C Imbert et al.
JOURNAL OF NEUROSCIENCE METHODS (2000)
Share Paper
